Chronic Activation of Liver X Receptor Induces β-Cell Apoptosis Through Hyperactivation of Lipogenesis

Liver X Receptor–Mediated Lipotoxicity in Pancreatic β-Cells

  1. Sung Sik Choe1,
  2. A Hyun Choi1,
  3. Joo-Won Lee1,
  4. Kang Ho Kim1,
  5. Jun-Jae Chung1,
  6. Jiyoung Park1,
  7. Kyeong-Min Lee2,
  8. Keun-Gyu Park3,
  9. In-Kyu Lee2 and
  10. Jae Bum Kim1
  1. 1Department of Biological Sciences, Research Center for Functional Cellulomics, Seoul National University, Seoul, South Korea
  2. 2Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea
  3. 3Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea
  1. Address correspondence and reprint requests to Jae Bum Kim, PhD, Department of Biological Sciences, Seoul National University, San 56-1, Sillim-Dong, Kwanak-Gu, Seoul, Korea. E-mail: jaebkim{at}snu.ac.kr

Abstract

Liver X receptor (LXR)α and LXRβ play important roles in fatty acid metabolism and cholesterol homeostasis. Although the functional roles of LXR in the liver, intestine, fat, and macrophages are well established, its role in pancreatic β-cells has not been clearly defined. In this study, we revealed that chronic activation of LXR contributes to lipotoxicity-induced β-cell dysfunction. We observed significantly elevated expression of LXR in the islets of diabetic rodent models, including fa/fa ZDF rats, OLETF rats, and db/db mice. In primary pancreatic islets and INS-1 insulinoma cells, activation of LXR with a synthetic ligand, T0901317, stimulated expression of the lipogenic genes ADD1/SREBP1c, FAS, and ACC and resulted in increased intracellular lipid accumulation. Moreover, chronic LXR activation induced apoptosis in pancreatic islets and INS-1 cells, which was synergistically promoted by high glucose conditions. Taken together, we suggest lipid accumulation caused by chronic activation of LXR in β-cells as a possible cause of β-cell lipotoxicity, a key step in the development of type 2 diabetes.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 16 March 2007. DOI: 10.2337/db06-1059.

  • Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db06-1059.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted March 12, 2007.
    • Received July 28, 2006.
« Previous | Next Article »Table of Contents